Decitabine Reprograms Temozolomide-Resistant Glioblastoma Through Epigenetic Reactivation and Mesenchymal Attenuation: A Multi-Omics Study.
Overview
- College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia
- King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh 12713, Saudi Arabia
- Department of Biosciences, Faculty of Science, Integral University, Lucknow 226026, India
- Stem Cell Biology Lab, Integral Center of Excellence for Interdisciplinary Research-4 (ICEIR-12), Integral University, Lucknow 226026, India
- King Faisal Specialist Hospital and Research Centre (KFSHRC), Jeddah 23433, Saudi Arabia
Abstract
Background/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
Datasets cited
- geo:GSE151680, at NCBI GEO; found in the text, “3.1. An Interferon-Activated, MYC-Suppressed…”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in “2.1. Public Datasets and Data Accessibility”
2.1. Public Datasets and Data Accessibility
All data were sourced from publicly available repositories. The datasets analyzed here are listed below (Table 1):
Raw data were downloaded from Gene Expression Omnibus (GEO [18]; https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Data Availability Statement
All data were sourced from publicly available repositories. The datasets analyzed here are listed below (Table 1):
Raw data were downloaded from Gene Expression Omnibus (GEO [18]; https://
The original data presented in the study are openly available in the Gene Expression Omnibus (GEO) at https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 12 authors, 11 keywords, 1 funder, 47 references.
Cite
This paper
Arora, I., Saleh, S. H., Akbar, A., Arshad, F., Mavrych, V., Bolgova, O., Farrash, F. A., Abu-Zaid, A., Khan, A., Muskan, S., Khan, M. I., & Yaqinuddin, A. (2026). Decitabine Reprograms Temozolomide-Resistant Glioblastoma Through Epigenetic Reactivation and Mesenchymal Attenuation: A Multi-Omics Study. Cancers, 18(16), 2616. https://
BibTeX
@article{arora2026decita
author = {Arora, Itika and Saleh, Shamsa Hilal and Akbar, Arshiya and Arshad, Fareeha and Mavrych, Volodymyr and Bolgova, Olena and Farrash, Faisal Abdulhameed and Abu-Zaid, Ahmed and Khan, Andleeb and Muskan, Sheikh and Khan, Mohammed Imran and Yaqinuddin, Ahmed},
title = {{Decitabine Reprograms Temozolomide-Resistant Glioblastoma Through Epigenetic Reactivation and Mesenchymal Attenuation: A Multi-Omics Study}},
journal = {Cancers},
year = {2026},
month = aug,
volume = {18},
number = {16},
pages = {2616},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2072-6694},
doi = {10.3390/
url = {https://
pmid = {42649932},
pmcid = {PMC13511076}
}
RIS
TY - JOUR
AU - Arora, Itika
AU - Saleh, Shamsa Hilal
AU - Akbar, Arshiya
AU - Arshad, Fareeha
AU - Mavrych, Volodymyr
AU - Bolgova, Olena
AU - Farrash, Faisal Abdulhameed
AU - Abu-Zaid, Ahmed
AU - Khan, Andleeb
AU - Muskan, Sheikh
AU - Khan, Mohammed Imran
AU - Yaqinuddin, Ahmed
TI - Decitabine Reprograms Temozolomide-Resistant Glioblastoma Through Epigenetic Reactivation and Mesenchymal Attenuation: A Multi-Omics Study
T2 - Cancers
J2 - Cancers (Basel)
PY - 2026
DA - 2026/
VL - 18
IS - 16
SP - 2616
SN - 2072-6694
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3390/
"type": "article-journal",
"title": "Decitabine Reprograms Temozolomide-Resistant Glioblastoma Through Epigenetic Reactivation and Mesenchymal Attenuation: A Multi-Omics Study",
"container-title": "Cancers",
"author": [
{
"family": "Arora",
"given": "Itika"
},
{
"family": "Saleh",
"given": "Shamsa Hilal"
},
{
"family": "Akbar",
"given": "Arshiya"
},
{
"family": "Arshad",
"given": "Fareeha"
},
{
"family": "Mavrych",
"given": "Volodymyr"
},
{
"family": "Bolgova",
"given": "Olena"
},
{
"family": "Farrash",
"given": "Faisal Abdulhameed"
},
{
"family": "Abu-Zaid",
"given": "Ahmed"
},
{
"family": "Khan",
"given": "Andleeb"
},
{
"family": "Muskan",
"given": "Sheikh"
},
{
"family": "Khan",
"given": "Mohammed Imran"
},
{
"family": "Yaqinuddin",
"given": "Ahmed"
}
],
"container-title-short":
"volume": "18",
"issue": "16",
"page": "2616",
"DOI": "10.3390/
"PMID": "42649932",
"PMCID": "PMC13511076",
"ISSN": "2072-6694",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
14
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3390/ijms27136068 [code]
- Loss of Neuropeptide Y Signaling Accompanies the Neural-to-Mesenchymal Transcriptional Transition in Glioblastoma: A Multi-Scale Transcriptomic Analysis.Journal: International journal of molecular sciencesIn common: genetics / omics, other condition, 7 references, 2 authors
- [2] doi:10.1016/j.cell.2026.05.026 [code]
- The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM.Journal: CellIn common: genetics / omics, other condition, 7 references
- [3] doi:10.1080/17501911.2026.2691031
- Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.Journal: EpigenomicsIn common: genetics / omics, other condition, 6 references
- [4] doi:10.1038/s41586-026-10612-6 [code]
- Acquired genetic and cell-state changes in IDH-mutant glioma progression.Journal: NatureIn common: other condition, 6 references
- [5] doi:10.1186/s12967-026-08266-z [code]
- Single-cell multi-omic integration analysis prioritizes druggable genes and reveals cell-type-specific causal effects in glioblastomagenesis.Journal: Journal of translational medicineIn common: genetics / omics, other condition, 5 references
- [6] doi:10.3390/cancers18132092
- TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activat
ed Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study. Journal: CancersIn common: genetics / omics, other condition, 5 references - [7] doi:10.1038/s41586-026-10515-6 [code]
- An X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism.Journal: NatureIn common: genetics / omics, 6 references
- [8] doi:10.1038/s41586-026-10679-1 [code]
- Cortical development dynamics across autism spectrum disorder mouse models.Journal: NatureIn common: genetics / omics, 6 references
- [9] doi:10.1016/j.xcrm.2026.102682 [code]
- TET CpG sequence-context-specifi
c DNA demethylation shapes progression of IDH-mutant gliomas. Journal: Cell reports. MedicineIn common: genetics / omics, other condition, 4 references - [10] doi:10.1128/mbio.01294-26
- Single-cell analysis of Powassan virus-infected brains reveals age-dependent neuroinflammatory crosstalk and progressive Alzheimer's-like APP/
Aβ accumulation. Journal: mBioIn common: genetics / omics, other condition, 5 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.